Laxative Effects of Taurine on Loperamide-Induced Constipation in Rats
In the present study, we investigated the laxative effects of taurine in a rat model of loperamide-induced constipation. Rats were divided into six groups of six animals each: normal (NOR), control (CON), loperamide + Dulcolax (5.5 mg/kg, p.o.), and loperamide + various doses of taurine (7.5, 15, and 30 mg/kg, p.o.). Laxative activity was determined based on body weight, feeding characteristics, fecal properties, gastrointestinal transit (GIT) ratio, and the levels of serum gastrointestinal hormones. Taurine supplementation significantly increased the number, wet weight, and water content of fecal pellets in rats with loperamide-induced constipation. GIT ratio and loperamide-induced serum metabolic parameters, such as gastrin (GAS), motilin (MTL), and somatostatin (SS) significantly changed after supplementation with taurine in loperamide-induced constipated rats. We suggest that taurine had a potent effect against loperamide-induced constipation in part by increasing gastrointestinal motility.
KeywordsConstipation Laxative effects Loperamide Taurine
calcitonin gene related peptide
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B01006822).
- Balkan J, Kanbağli O, Hatipoğlu A, Kücük M, Cevikbaş U, Aykaç-Toker G, Uysal M (2002) Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 66:1755–1758. https://doi.org/10.1271/bbb.66.1755CrossRefPubMedGoogle Scholar
- Çetiner M, Şener G, Şehirli AÖ, Ekşioğlu-Demiralp E, Ercan F, Şirvancı S, Gedik N, Akpulat S, Tecimer T, Yeğen BÇ (2005) Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol 209:39–50. https://doi.org/10.1016/j.taap.2005.03.009CrossRefPubMedGoogle Scholar
- Fukudo S, Hongo M, Kaneko H, Ueno R (2011) Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 23:544–e205. https://doi.org/10.1111/j.1365-2982.2011.01668.xCrossRefPubMedGoogle Scholar
- Kakino M, Izuta H, Ito T, Tsuruma K, Araki Y, Shimazawa M, Oyama M, Iinuma M, Hara H (2010) Agarwood induced laxative effects via acetylcholine receptors on loperamide-induced constipation in mice. Biosci Biotechnol Biochem 74:1550–1555. https://doi.org/10.1271/bbb.100122CrossRefPubMedGoogle Scholar
- Lee HY, Kim JH, Jeung HW, Lee CU, Kim DS, Li B, Lee GH, Sung MS, Ha KC, Back HI, Kim SY, Park SH, Oh MR, Kim MG, Jeon JY, Im YJ, Hwang MH, So BO, Shin SJ, Yoo WH, Kim HR, Chae HJ, Chae SW (2012) Effects of Ficus carica paste on loperamide induced constipation in rats. Food Chem Toxicol 50:895–902. https://doi.org/10.1016/j.fct.2011.12.001CrossRefPubMedGoogle Scholar
- Shuai Yan, Yin-zi Yue, Xiao-peng Wang, Hong-li Dong, Shu-guang Zhen, Ben-sheng Wu, Hai-hua Qian (2017) Aqueous extracts of promoted intestinal motility in loperamide-induced constipation rats by ameliorating the interstitial cells of cajal. Evid Based Complement Alternat Med 2017:1–13Google Scholar